Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
复制标题
开发 δ 阿片受体药效团模型。
DOI:
10.1021/jm00051a016
复制
发表时间:
1994
影响因子:
7.3
通讯作者:
Porreca,F
中科院分区:
文献类型:
--
作者:
Mosberg,HI;Omnaas,JR;Lomize,A;Heyl,DL;Nordan,I;Mousigian,C;Davis,P;Porreca,F
The in vitro pharmacological properties and conformational features of analogs of the ó opioid receptor selective tetrapeptide Tyr-c [D-Cys-Phe-D-Pen] OH (JOM-13) in which the Phe3 residue was replaced by each of the four stereoisomers of/3-methylphenylalanine (/3-MePhe) were investigated. Both analogs in which the a carbon of the Phe3 replacement has L-stereochemistry display high affinity for receptors with the (2S, 3S)-MePhe3 analog exhibiting approximately 8-fold higher affinity than the (2S, 3i?)-MePhe3 diastereomer. Surprisingly, one analog with D-stereochemistry in residue 3, the (2ñ, 3i?)-MePhe3 analog, also displays high affinity for the receptor and is extraordinarily selective for this receptor. All analogs were agonists in the mouse vas deferens (MVD) and guinea pig ileum (GPI) smooth muscle bioassays, displaying MVD and GPI potencies consistent with their ó and µ opioid receptor affinities, respectively. The use of/3-MePhe as a replacement for Phe3 was based uponthe desire to reduce the conformational flexibility of the Phe3 side chain by imposing a steric rotational constraint in the form of the/3-methyl substituent and to thus deduce the residue 3 side chainorientation in the receptor-bound conformation from the correlation between receptor binding affinities and conformational preferences. Molecular mechanics computations revealed, however, that the conformational constraints imposed by the/3-methyl group in the (2S, 3S)-MePhe3 and (2S, 3i?)-MePhe3 analogs were too modest to allow unequivocal determination of receptor-bound residue 3 side chain conformation. However, analysis of the high-affinity (2i?, 32?)-MePhe3 analog revealed a strong preference for a single side chain conformer (1~